These heterogeneities, in addition to the small numbers of cases available for each study, may explain the disparate clinical outcomes reported for MYC/BCL6-DH DLBCL [14, 17, 18]. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.